HSI1 25,796.29 -96.73 157.66B
HSCEI1 8,634.55 -42.76 48.90B
Back    Zoom +    Zoom - Block Traded
Deloitte: HK Ranks First Globally in 1Q26 IPO Fundraising, Middle East Tensions Prompt Capital Reallocation
2026-04-08 13:22:21
Deloitte stated that in 1Q26, Hong Kong continued to rank first globally in IPO fundraising. During the period, 40 new listings were completed, raising more than HKD109.9 billion, representing a YoY increase of approximately 504%. Nasdaq and the New York Stock Exchange ranked second and third, with fundraising amounts of about HKD44 billion and HKD40.2 billion, respectively.

The firm expects Hong Kong to rank among the global top three in IPO fundraising for the full year, with around 160 new listings and total fundraising of at least HKD300 billion. Most listing applicants are leading Chinese enterprises, existing A-share issuers and companies seeking overseas expansion. Among them, about seven companies are expected to raise at least USD1 billion each. Hong Kong's listing pipeline will be dominated by the TMT sector, particularly AI, as well as life sciences and pharmaceutical companies.

Au Chun Hing, Deloitte China Southern Region Managing Partner, said that although geopolitical factors have caused market volatility, they have also prompted global investors to reallocate capital, with Asia viewed as a relatively safe region. Regarding companies postponing listings in 1Q26, Au noted that these were company-specific issues. The market is not short of capital, but funds may be more selective, with investors becoming more cautious and sensitive to valuations, while Hong Kong continues to retain its advantages.

In response to the Hong Kong Securities and Futures Commission tightening limits on the number of projects handled by sponsors, Au said the regulation can help ensure the quality of listed companies and will support the healthy development of the IPO market in the long run. (ss/da)~

AASTOCKS Financial News
Website: www.aastocks.com

This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.